Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia

Published:2018-03-28 Issue:1 Volume:19 Page:55-74
ISSN:1389-2002
Container-title:Current Drug Metabolism
language:en
Short-container-title:CDM

Author:

Megias-Vericat Juan Eduardo¹,Martinez-Cuadron David²,Herrero Maria Jose¹,Alino Salvador F.¹,Poveda Jose Luis³,Sanz Miguel Angel²,Montesinos Pau²

Affiliation:

1. Unidad de Farmacogenetica, Instituto Investigacion Sanitaria La Fe and Area del Medicamento, Hospital Universitario y Politecnico La Fe. Avda. Fernando Abril Martorell 106, 46026 - Valencia, Spain

2. Servicio de Hematologia y Hemoterapia. Hospital Universitario y Politecnico La Fe. Avda. Fernando Abril Martorell 106, 46026 – Valencia, Spain

3. Servicio de Farmacia, Area del Medicamento. Hospital Universitario y Politecnico La Fe Avda. Fernando Abril Martorell 106, 46026 - Valencia, Spain

Publisher

Bentham Science Publishers Ltd.

Subject

Clinical Biochemistry,Pharmacology

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polygenic markers of survival and longevity in the antioxidant genes PON1, PON2, MTHFR, MSRA, SOD1, NQO1, and CAT in a 20-year follow-up study in the population from the Volga-Ural region;Gene;2024-08

2. Can pharmacogenetics impact the therapeutic effect of cytarabine and anthracyclines in adult acute myeloid leukaemia patients?: A Serbian experience;Journal of Medical Biochemistry;2024

3. Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy;Cancers;2023-06-11

4. Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia;Cancers;2023-04-12

5. A Pan-Cancer Landscape of ABCG2 across Human Cancers: Friend or Foe?;International Journal of Molecular Sciences;2022-12-15